BriaCell Therapeutics Corp. (BCTX)
NASDAQ: BCTX · Real-Time Price · USD
4.490
-0.370 (-7.61%)
At close: Jan 15, 2026, 4:00 PM EST
4.330
-0.160 (-3.56%)
Pre-market: Jan 16, 2026, 5:57 AM EST
BriaCell Therapeutics Market Cap
BriaCell Therapeutics has a market cap or net worth of $8.47 million as of January 16, 2026. Its market cap has decreased by -65.55% in one year.
Market Cap
8.47M
Enterprise Value
-2.42M
1-Year Change
-65.55%
Ranking
Category
Stock Price
$4.49
Market Cap Chart
Since February 24, 2021, BriaCell Therapeutics's market cap has decreased from $26.00M to $8.47M, a decrease of -67.40%. That is a compound annual growth rate of -20.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 14, 2026 | 9.20M | -31.34% |
| Dec 31, 2025 | 13.40M | -46.40% |
| Dec 31, 2024 | 25.00M | -73.26% |
| Dec 29, 2023 | 93.50M | 37.91% |
| Dec 30, 2022 | 67.80M | -46.74% |
| Dec 31, 2021 | 127.30M | 389.62% |
| Feb 24, 2021 | 26.00M | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 964.49B |
| Johnson & Johnson | 514.75B |
| AbbVie | 390.15B |
| UnitedHealth Group | 302.49B |
| AstraZeneca | 291.77B |
| Novartis AG | 272.12B |
| Merck & Co. | 268.70B |
| Novo Nordisk | 265.30B |